Control of Nitrosamine Impurities in Human Drugs
Good Manufacturing Practice (CGMP) to address the control of nitrosamine impurities in human drugs. The guidance is being issued without prior public comment due to the need to provide manufacturers...
Control of Nitrosamine Impurities, list of Nitrosamine Impurities, Nitrosamine Impurities guidelines, Nitrosamine Impurities in Drugs, Nitrosamine Impurities in Human Drugs, Nitrosamine Impurity